Synthesis and in-vitro potency of novel quinazolinone-based vitronectin receptor antagonists.

被引：0

作者：

Lawson, EC ^{[1
]}

Costanzo, MJ ^{[1
]}

Hoekstra, WJ ^{[1
]}

Kinney, WA ^{[1
]}

Luci, DK ^{[1
]}

Maryanoff, BE ^{[1
]}

Wisnoski, D ^{[1
]}

Yabut, SC ^{[1
]}

Andrade-Gordon, P ^{[1
]}

Kauffman, JA ^{[1
]}

Santulli, R ^{[1
]}

机构：

[1] RW Johnson Pharmaceut Res Inst, Spring House, PA 19477 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 222卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

78-MEDI

引用

页码：U652 / U653

页数：2

共 50 条

[21] Pharmacological profile of a novel series of NK1 antagonists.: In vitro and in vivo potency of benzimidazolone derivatives
Rémond, G
Portevin, B
Bonnet, J
Canet, E
Regoli, D
De Nanteuil, G
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1997, 32 (11) : 843 - 868
[22] Discovery of novel human glucagon receptor antagonists.
Shen, DM
Zhang, F
Brady, EJ
Candelore, MR
Ding, VDH
Jiang, G
Mock, S
Qureshi, SA
Saperstein, R
Tamvakopoulos, C
Tong, X
Tota, LM
Wright, M
Zheng, S
Chapman, KT
Zhang, BB
Tata, JR
Parmee, E
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U121 - U121
[23] Design and Synthesis of Novel Quinazolinone-Based Oxobutanenitrile Derivatives as Antiproliferative Agents Targeting Human Breast Cancer
AboulWafa, Omaima Mohamed
Daabees, Hoda Mohamed Gamal El-Din
Ezz-ElDien, Eman Salah
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (12) : 2310 - 2326
[24] Synthesis and SARs of novel piperazine derivatives as melanocortin-4 receptor antagonists.
Nakazato, A
Ishii, T
Okubo, T
Nozawa, D
Chaki, S
Ueki, T
Okuyama, S
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U917 - U917
[25] Thiophene-based vitronectin receptor antagonists
Bubenik, M
Meerovitch, K
Bergeron, F
Attardo, G
Chan, L
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 503 - 506
[26] Novel chalcones as nonpeptide GPIIb/IIIa receptor antagonists.
Cain, GA
Bostrom, LL
DiMeo, SV
Mousa, SA
Eyermann, CJ
Olson, RE
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 133 - MEDI
[27] A novel series of potent, ET(A) selective, receptor antagonists.
Gao, AM
Lago, MA
Nambi, P
Ohlstein, EH
Elliott, JD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 141 - MEDI
[28] Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists.
vanRhee, AM
Siddiqi, SM
Melman, N
Shi, D
Padgett, WL
Daly, JW
Jacobson, KA
FASEB JOURNAL, 1996, 10 (03): : 784 - 784
[29] Design, synthesis, and oral efficacy of novel vitronectin receptor antagonists in tumor models.
Khanna, IK
Chandrakumar, NS
Devadas, B
Desai, BN
Gaslecki, AF
Huff, R
Ruminski, PG
Russell, MA
Yu, Y
Carron, CP
Duffin, T
Engleman, W
Freeman, S
Keene, JL
Meyer, DM
Nickols, GA
Nickols, MA
Pegg, JA
Settle, SL
Westlin, MM
Westlin, WF
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U47 - U47
[30] Synthesis, Characterization, Antibacterial Evaluation, and Molecular Docking of New Quinazolinone-Based Derivatives
Dehbi, Oussama
Riadi, Yassine
Geesi, Mohammed H.
Anouar, El Hassane
Ibnouf, Elmutasim O.
Azzallou, Rachid
POLYCYCLIC AROMATIC COMPOUNDS, 2023, 43 (02) : 1879 - 1887

← 1 2 3 4 5 →